Suppr超能文献

关于建立短杆菌肽第二个国际标准的协作研究。

Collaborative study for the establishment of the second international standard for gramicidin.

作者信息

Rautmann G, Daas A, Buchheit K-H

机构信息

European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.

出版信息

Pharmeur Bio Sci Notes. 2010 Oct;2010(2):56-67.

Abstract

An international collaborative study was organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM) to establish the WHO second International Standard (IS) for gramicidin as the stocks of the 1st IS, established in 1964, were close to depletion. The candidate material did not show any sign of potency loss when kept at elevated temperatures of + 4 °C, + 20 °C, + 37 °C and + 45 °C for 3 months. Six laboratories from 5 countries as well as the EDQM laboratory participated in the collaborative study. Potencies of the candidate material were estimated by microbiological assays with sensitive micro-organisms. To ensure continuity between consecutive batches, the 1st IS for gramicidin was used as standard. Based on the results of the study, the 2nd IS for gramicidin was adopted at the meeting of the WHO Expert Committee on Biological Standardization (ECBS) in 2008 with an assigned potency of 1070 International Units per mg (IU/mg). The 2nd IS for gramicidin is available from the EDQM.

摘要

欧洲药品质量管理局(EDQM)组织了一项国际合作研究,旨在建立世卫组织的第二个短杆菌肽国际标准品(IS),因为1964年建立的第一个国际标准品库存已接近耗尽。候选材料在+4°C、+20°C、+37°C和+45°C的高温下保存3个月时,未显示出任何效价损失的迹象。来自5个国家的6个实验室以及EDQM实验室参与了这项合作研究。通过使用敏感微生物的微生物学测定法来估计候选材料的效价。为确保连续批次之间的连续性,短杆菌肽的第一个国际标准品用作标准。根据研究结果,2008年在世卫组织生物标准化专家委员会(ECBS)会议上采用了短杆菌肽的第二个国际标准品,指定效价为每毫克1070国际单位(IU/mg)。短杆菌肽的第二个国际标准品可从EDQM获得。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验